Related Experiment Videos
Plasmablastic transformation of multiple myeloma
Cheuk Kwong Lee1, Edmond S K Ma, Tony W H Shek
1Department of Pathology, The University of Hong Kong, Queen Mary Hospital.
Human Pathology
|July 23, 2003
Summary
This study details a rare case of multiple myeloma (MM) progressing to acute leukemia-like plasmablastic transformation. This transformation involved myeloid and megakaryocytic markers, highlighting a critical diagnostic consideration in advanced MM.
Area of Science:
- Hematology
- Oncology
- Cancer Biology
Background:
- Multiple myeloma (MM) is a hematologic malignancy characterized by malignant plasma cells.
- Disease progression in MM can involve diverse morphologic and genetic changes.
- Plasmablastic transformation is a rare but significant event in the terminal phase of MM.
Observation:
- A unique case of MM exhibited plasmablastic transformation resembling acute leukemia.
- The transformed plasmablasts displayed monotypic cytoplasmic immunoglobulin, alongside myeloid and megakaryocytic markers.
- Bone marrow cytogenetics revealed a predominant hypodiploid clone alongside a hyperdiploid clone.
Findings:
- The study provides a comprehensive characterization of a rare plasmablastic transformation in multiple myeloma.
- Immunophenotypic analysis revealed co-expression of myeloid and megakaryocytic markers on plasmablasts during transformation.
- Cytogenetic analysis identified a predominant hypodiploid clone, suggesting complex genomic alterations.
Implications:
- Plasmablastic transformation should be considered in the differential diagnosis of disease progression in multiple myeloma.
- Distinguishing de novo plasmablastic myeloma from transformation of underlying MM requires further investigation.
- Understanding the biologic features and prognostic relevance of plasmablastic transformation is crucial for patient management.